137 related articles for article (PubMed ID: 8641644)
1. NADPH oxidase activity and chemotaxis by neutrophils in two patients with glycogen storage disease type Ib treated with recombinant human granulocyte-monocyte colony-stimulating factor.
Piva E; De Toni S; Bovo C; Bordugo A; Burlina AB; Plebani M
Haematologica; 1996; 81(2):148-51. PubMed ID: 8641644
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization.
McCawley LJ; Korchak HM; Douglas SD; Campbell DE; Thornton PS; Stanley CA; Baker L; Kilpatrick L
Pediatr Res; 1994 Jan; 35(1):84-90. PubMed ID: 7510873
[TBL] [Abstract][Full Text] [Related]
3. The effects of stem cell factor and granulocyte colony stimulating factor therapy on the activity of the neutrophil NADPH oxidase enzyme system.
Leavey PJ; Thurman G; Gonzalez-Aller C; Zerbe G; Ambruso DR
J Investig Med; 1998 Apr; 46(4):121-6. PubMed ID: 9635370
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human G-CSF (Lenograstim) for infectious complications in glycogen storage disease type Ib. Report of 7 cases.
Donadieu J; Bader-Meunier B; Bertrand Y; Lachaux A; Labrune P; Gougerot-Pocidalo MA; Odièvre M; Gibeaud P; Yver A; Tchernia G
Nouv Rev Fr Hematol (1978); 1994; 35(6):529-34. PubMed ID: 7512258
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte and granulocyte-macrophage colony-stimulating factors for treatment of neutropenia in glycogen storage disease type Ib.
Schroten H; Roesler J; Breidenbach T; Wendel U; Elsner J; Schweitzer S; Zeidler C; Burdach S; Lohmann-Matthes ML; Wahn V
J Pediatr; 1991 Nov; 119(5):748-54. PubMed ID: 1719175
[TBL] [Abstract][Full Text] [Related]
6. Impaired glucose homeostasis, neutrophil trafficking and function in mice lacking the glucose-6-phosphate transporter.
Chen LY; Shieh JJ; Lin B; Pan CJ; Gao JL; Murphy PM; Roe TF; Moses S; Ward JM; Lee EJ; Westphal H; Mansfield BC; Chou JY
Hum Mol Genet; 2003 Oct; 12(19):2547-58. PubMed ID: 12925567
[TBL] [Abstract][Full Text] [Related]
7. The effects of treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on human polymorphonuclear leukocyte function.
Buescher ES; McIlheran SM; Banks SM; Vadhan-Raj S
Exp Hematol; 1993 Oct; 21(11):1467-72. PubMed ID: 8405227
[TBL] [Abstract][Full Text] [Related]
8. Long term G-CSF-induced remission of ulcerative colitis-like inflammatory bowel disease in a patient with glycogen storage disease Ib and evaluation of associated neutrophil function.
Alsultan A; Sokol RJ; Lovell MA; Thurman G; Ambruso DR
Pediatr Blood Cancer; 2010 Dec; 55(7):1410-3. PubMed ID: 20830779
[TBL] [Abstract][Full Text] [Related]
9. Orthotopic liver transplantation for glycogen storage disease type Ib--treatment with recombinant human granulocyte colony-stimulating factor.
Lachaux A; Boillot O; Stamm D; Canterino I; Regnier F; Regragui K; Floret D; Hermier M
Transplant Proc; 1994 Feb; 26(1):265. PubMed ID: 7509094
[No Abstract] [Full Text] [Related]
10. Impaired chemotaxis and neutrophil (polymorphonuclear leukocyte) function in glycogenosis type IB.
Koven NL; Clark MM; Cody CS; Stanley CA; Baker L; Douglas SD
Pediatr Res; 1986 May; 20(5):438-42. PubMed ID: 3459131
[TBL] [Abstract][Full Text] [Related]
11. A convenient diagnostic function test of peripheral blood neutrophils in glycogen storage disease type Ib.
Verhoeven AJ; Visser G; van Zwieten R; Gruszczynska B; Tien Poll-The DW; Smit GP
Pediatr Res; 1999 Jun; 45(6):881-5. PubMed ID: 10367783
[TBL] [Abstract][Full Text] [Related]
12. Improvement of neutropenia and neutrophil dysfunction by granulocyte colony-stimulating factor in a patient with glycogen storage disease type Ib.
Ishiguro A; Nakahata T; Shimbo T; Amano Y; Yasui K; Koike K; Komiyama A
Eur J Pediatr; 1993 Jan; 152(1):18-20. PubMed ID: 7680314
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil adherence receptor deficiency regressing with granulocyte-colony stimulating factor therapy in a case of glycogen storage disease type Ib.
Latger-Cannard V; Marchand-Arvier M; Vidailhet M; Donadieu J; Vigneron C; Bordigoni P
Eur J Pediatr; 2002 Feb; 161(2):87-93. PubMed ID: 11954758
[TBL] [Abstract][Full Text] [Related]
14. Growth factors G-CSF and GM-CSF differentially preserve chemotaxis of neutrophils aging in vitro.
Wolach B; van der Laan LJ; Maianski NA; Tool AT; van Bruggen R; Roos D; Kuijpers TW
Exp Hematol; 2007 Apr; 35(4):541-50. PubMed ID: 17379064
[TBL] [Abstract][Full Text] [Related]
15. Treatment of chronic wounds by local delivery of granulocyte-macrophage colony-stimulating factor in patients with neutrophil dysfunction.
De Ugarte DA; Roberts RL; Lerdluedeeporn P; Stiehm ER; Atkinson JB
Pediatr Surg Int; 2002 Sep; 18(5-6):517-20. PubMed ID: 12415398
[TBL] [Abstract][Full Text] [Related]
16. Nicotinamide effects oxidative burst activity of neutrophils in patients with poorly controlled type 2 diabetes mellitus.
Osar Z; Samanci T; Demirel GY; Damci T; Ilkova H
Exp Diabesity Res; 2004; 5(2):155-62. PubMed ID: 15203886
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
Root RK; Dale DC
J Infect Dis; 1999 Mar; 179 Suppl 2():S342-52. PubMed ID: 10081506
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte colony-stimulating factor corrects the neutropenia associated with glycogen storage disease type Ib.
Wang WC; Crist WM; Ihle JN; Arnold BA; Keating JP
Leukemia; 1991 Apr; 5(4):347-9. PubMed ID: 1709246
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of chemotactic peptide-induced activation of phosphoinositide 3-kinase by granulocyte-macrophage colony-stimulating factor and its relation to the cytokine-mediated priming of neutrophil superoxide-anion production.
Kodama T; Hazeki K; Hazeki O; Okada T; Ui M
Biochem J; 1999 Jan; 337 ( Pt 2)(Pt 2):201-9. PubMed ID: 9882616
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte macrophage-colony stimulating factor delays neutrophil apoptosis and primes its function through Ia-type phosphoinositide 3-kinase.
Yasui K; Sekiguchi Y; Ichikawa M; Nagumo H; Yamazaki T; Komiyama A; Suzuki H
J Leukoc Biol; 2002 Nov; 72(5):1020-6. PubMed ID: 12429725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
